Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Michael S. Argenyi, Joni K. Evans, Yasmin Gay, David H. Epstein & Stephanie T. Weiss. (2023) The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees. Clinical Toxicology 61:7, pages 509-517.
Read now
Read now
Sarah G. Mahonski, James B. Leonard, J. David Gatz, Hyunuk Seung, Erin E. Haas & Hong K. Kim. (2020) Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data. Clinical Toxicology 58:2, pages 117-123.
Read now
Read now
Hong K. Kim, Nicholas J. Connors & Maryann E. Mazer-Amirshahi. (2019) The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs. Expert Opinion on Drug Safety 18:6, pages 465-475.
Read now
Read now
Mark J. Elzey, Jeffrey Fudin & Eric S. Edwards. (2017) Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems. Expert Opinion on Drug Delivery 14:9, pages 1045-1058.
Read now
Read now
Mark Faul, Peter Lurie, Jeremiah M. Kinsman, Michael W. Dailey, Charmaine Crabaugh & Scott M. Sasser. (2017) Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing. Prehospital Emergency Care 21:4, pages 411-419.
Read now
Read now
Scott G. Weiner, Patricia M. Mitchell, Elizabeth S. Temin, Breanne K. Langlois & K. Sophia Dyer. (2017) Use of Intranasal Naloxone by Basic Life Support Providers. Prehospital Emergency Care 21:3, pages 322-326.
Read now
Read now
Michael Levine, Stephen Sanko & Marc Eckstein. (2016) Assessing the Risk of Prehospital Administration of Naloxone with Subsequent Refusal of Care. Prehospital Emergency Care 20:5, pages 566-569.
Read now
Read now
Matthew Zuckerman, Stacy N. Weisberg & Edward W. Boyer. (2015) Pitfalls of Intranasal Narcan – Response to a Letter to the Editor. Prehospital Emergency Care 19:1, pages 138-139.
Read now
Read now
Corey S. Davis, Caleb J. Banta-Green, Phillip Coffin, Michael W. Dailey & Alexander Y. Walley. (2015) Intranasal Naloxone for Opioid Overdose Reversal. Prehospital Emergency Care 19:1, pages 135-137.
Read now
Read now
Articles from other publishers (29)
Eric J. Lavonas, Peter D. Akpunonu, Ann M. Arens, Kavita M. Babu, Dazhe Cao, Robert S. Hoffman, Christopher O. Hoyte, Maryann E. Mazer-Amirshahi, Andrew Stolbach, Maude St-Onge, Trevonne M. Thompson, George Sam Wang, Amber V. Hoover & Ian R. Drennan. (2023) 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation.
Crossref
Crossref
Akeemat O. Tijani, Amruta A. Dandekar, Tanvi Karve, Ajay K. Banga & Ashana Puri. (2023) Transdermal delivery of naloxone hydrochloride using minimally invasive physical ablation techniques. International Journal of Pharmaceutics 642, pages 123159.
Crossref
Crossref
Ngocdung T. Tran, Ibrahim K. Muradian, Nazia Qureshi, Jimmy Singh & Sean O. Henderson. (2023) Characterizing and combating the opioid epidemic in the Los Angeles County jail system. Journal of Substance Use and Addiction Treatment 147, pages 208984.
Crossref
Crossref
N. Cavanagh, I. E. Blanchard, D. Weiss & W. Tavares. (2023) Looking back to inform the future: a review of published paramedicine research. BMC Health Services Research 23:1.
Crossref
Crossref
Marta Tikhomirov, Paweł Jajor, Tomasz Śniegocki & Błażej Poźniak. (2022) Predicting the efficacy of opioid sequestration by intravenous lipid emulsion using biologically relevant in vitro models of drug distribution. Scientific Reports 12:1.
Crossref
Crossref
Stevie C. Britch & Sharon L. Walsh. (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology 239:7, pages 2063-2081.
Crossref
Crossref
Andrew J. Kassick, Mariah Wu, Diego Luengas, Mohammad Ebqa’ai, L. P. Tharika Nirmani, Nestor Tomycz, Toby L. Nelson, Marco Pravetoni, Michael D. Raleigh & Saadyah Averick. (2021) Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning. ACS Pharmacology & Translational Science 4:5, pages 1654-1664.
Crossref
Crossref
Alex S. Bennett & Luther Elliott. (2021) Naloxone's role in the national opioid crisis—past struggles, current efforts, and future opportunities. Translational Research 234, pages 43-57.
Crossref
Crossref
Miriam Boeri & Aukje K. Lamonica. (2021) Naloxone perspectives from people who use opioids: Findings from an ethnographic study in three states. Journal of the American Association of Nurse Practitioners 33:4, pages 294-303.
Crossref
Crossref
Ashish R. Panchal, Jason A. Bartos, José G. Cabañas, Michael W. Donnino, Ian R. Drennan, Karen G. Hirsch, Peter J. Kudenchuk, Michael C. Kurz, Eric J. Lavonas, Peter T. Morley, Brian J. O’Neil, Mary Ann Peberdy, Jon C. Rittenberger, Amber J. Rodriguez, Kelly N. Sawyer, Katherine M. Berg, Julie Arafeh, Justin L. Benoit, Maureen Chase, Antonio Fernandez, Edison Ferreira de Paiva, Bryan L. Fischberg, Gustavo E. Flores, Peter Fromm, Raul Gazmuri, Blayke Courtney Gibson, Theresa Hoadley, Cindy H. Hsu, Mahmoud Issa, Adam Kessler, Mark S. Link, David J. Magid, Keith Marrill, Tonia Nicholson, Joseph P. Ornato, Garrett Pacheco, Michael Parr, Rahul Pawar, James Jaxton, Sarah M. Perman, James Pribble, Derek Robinett, Daniel Rolston, Comilla Sasson, Sree Veena Satyapriya, Travis Sharkey, Jasmeet Soar, Deb Torman, Benjamin Von Schweinitz, Anezi Uzendu, Carolyn M. Zelop & David J. Magid. (2020) Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 142:16_suppl_2.
Crossref
Crossref
Alexis A. Topjian, Tia T. Raymond, Dianne Atkins, Melissa Chan, Jonathan P. Duff, Benny L. JoynerJrJr, Javier J. Lasa, Eric J. Lavonas, Arielle Levy, Melissa Mahgoub, Garth D. Meckler, Kathryn E. Roberts, Robert M. Sutton, Stephen M. Schexnayder, Ronald A. Bronicki, Allan R. de Caen, Anne Marie Guerguerian, Kelly D. Kadlec, Monica E. Kleinman, Lynda J. Knight, Taylor N. McCormick, Ryan W. Morgan, Joan S. Roberts, Barnaby R. Scholefield, Sarah Tabbutt, Ravi Thiagarajan, Janice Tijssen, Brian Walsh & Arno Zaritsky. (2020) Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 142:16_suppl_2.
Crossref
Crossref
Andrew J. Kassick, Heather N. Allen, Saigopalakrishna S. Yerneni, Fathima Pary, Marina Kovaliov, Cooper Cheng, Marco Pravetoni, Nestor D. Tomycz, Donald M. Whiting, Toby L. Nelson, Michael Feasel, Phil G. Campbell, Benedict Kolber & Saadyah Averick. (2019) Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone. ACS Applied Bio Materials 2:8, pages 3418-3428.
Crossref
Crossref
Francis Melaragni, Carly Levy, Jennifer Pedrazzi & Merissa Andersen. (2019) Assessing pharmacists’ readiness to dispense naloxone and counsel on responding to opioid overdoses. Journal of the American Pharmacists Association 59:4, pages 550-554.e2.
Crossref
Crossref
Jeffrey Fudin, Amelia L Persico, Jeffrey J Bettinger & Erica L Wegrzyn. (2019) The state of naloxone: Access amid a public health crisis. Medicine Access @ Point of Care 3, pages 239920261984763.
Crossref
Crossref
S. Mallory Burns, Christopher W. Cunningham & Susan L. Mercer. (2018) DARK Classics in Chemical Neuroscience: Fentanyl. ACS Chemical Neuroscience 9:10, pages 2428-2437.
Crossref
Crossref
Phil Skolnick. (2018) On the front lines of the opioid epidemic: Rescue by naloxone. European Journal of Pharmacology 835, pages 147-153.
Crossref
Crossref
Phil Skolnick. (2018) The Opioid Epidemic: Crisis and Solutions. Annual Review of Pharmacology and Toxicology 58:1, pages 143-159.
Crossref
Crossref
Rachael Rzasa Lynn & JL Galinkin. (2017) Naloxone dosage for opioid reversal: current evidence and clinical implications. Therapeutic Advances in Drug Safety 9:1, pages 63-88.
Crossref
Crossref
Hannah R. Fudin, Jennifer L. Babin, Lisa T. Hong, Jennifer Ku, Alisyn L. May, Alexander Wisner, F. Scott Hall & Sidhartha D. Ray. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
29
89
.
BT Gufford, GR Ainslie, JR WhiteJrJr, ME Layton, JM Padowski, GM Pollack & MF Paine. (2017) Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies. Clinical and Translational Science 10:5, pages 380-386.
Crossref
Crossref
Matthew P. Prekupec, Peter A. Mansky & Michael H. Baumann. (2017) Misuse of Novel Synthetic Opioids: A Deadly New Trend. Journal of Addiction Medicine 11:4, pages 256-265.
Crossref
Crossref
Ida Tylleskar, Arne Kristian Skulberg, Turid Nilsen, Sissel Skarra, Phatsawee Jansook & Ola Dale. (2017) Pharmacokinetics of a new, nasal formulation of naloxone. European Journal of Clinical Pharmacology 73:5, pages 555-562.
Crossref
Crossref
Phillip A. Saccone, Angela M. Lindsey, Robert A. Koeppe, Kathy A. Zelenock, Xia Shao, Phillip Sherman, Carole A. Quesada, James H. Woods & Peter J. H. Scott. (2016) Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception. Journal of Pharmacology and Experimental Therapeutics 359:2, pages 366-373.
Crossref
Crossref
Philip Krieter, Nora Chiang, Shwe Gyaw, Phil Skolnick, Roger Crystal, Fintan Keegan, Julie Aker, Melissa Beck & Jennifer Harris. (2016) Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose. The Journal of Clinical Pharmacology 56:10, pages 1243-1253.
Crossref
Crossref
John Strang, Rebecca McDonald, Basak Tas & Ed Day. (2016) Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?. Addiction 111:4, pages 574-582.
Crossref
Crossref
Marco L.A. Sivilotti. (2016) Flumazenil, naloxone and the ‘coma cocktail’. British Journal of Clinical Pharmacology 81:3, pages 428-436.
Crossref
Crossref
Eric J. Lavonas, Ian R. Drennan, Andrea Gabrielli, Alan C. Heffner, Christopher O. Hoyte, Aaron M. Orkin, Kelly N. Sawyer & Michael W. Donnino. (2015) Part 10: Special Circumstances of Resuscitation. Circulation 132:18_suppl_2.
Crossref
Crossref
. (2015) Fentanyl. Reactions Weekly 1558:1, pages 86-86.
Crossref
Crossref
Robert S. Hoffman. (2014) Inadequate pain control versus opioid abuse: It is time for the pendulum to swing. American Journal of Health-System Pharmacy 71:18, pages 1537-1537.
Crossref
Crossref